Former UFC heavyweight champion has been notified by the US Anti-Doping Agency of a failed out-of-competition medicine exam on 28 June
Brock Lesnar has been flagged for a potential anti-doping contravention in the wake of his unanimous-decision win over Mark Hunt at UFC 200.
The UFC questioned a declaration on Friday afternoon saying Lesnar and the advertising had been notified by the US Anti-Doping Agency of a failed out-of-competition medication exam on 28 June. Usada did not uncover the name of the substance Lesnar tested positive for in keeping with organizational policy.
A embellished amateur wrestler, Lesnar signed with the UFC in 2007 and thwarted Randy Couture for the advertisings heavyweight championship the following year. He acquired two successful entitlement securities before losing to Cain Velasquez by first-round TKO, then announced his retirement from motley martial arts after a stoppage loss to Alistair Overeem in 2011.
Saturdays fight with Hunt was Lesnars firstly in five years old. The 38 -year-old South Dakota native payed a record $2.5 m handbag for the three-round phases win, with all three judges siding down scores of 29 -2 8.
The UFC said Usada, the independent administrator of the organizations anti-doping program, received the testing results from the 28 June sample collecting on Thursday evening after it was tested at the Wada-accredited UCLA Olympic Analytical Laboratory.
The original headline bout of Saturdays card a light-headed heavyweight entitlement fighting between Jon Jones and Daniel Cormier was scrapped when Jones tested positive for a banned substance. Cormier instead engaged Anderson Silva on the undercard, while the womens bantamweight championship contend between Amanda Nunes and Miesha Tate was heightened to the main event.
The UFC 200 main event had to be scrapped three days before the incident because Jon Jones is positive for censored elements in an out-of-competition exam. Daniel Cormier campaigned Anderson Silva instead. Jones is also awaiting the USADA adjudication process.
Read more: www.theguardian.com